Amelioration of cognitive impairment following growth hormone replacement therapy: A case report and review of literature

Figure 1 Body composition and serum markers. A: The values of insulin-like growth factor-1 (upper) and lipid profiles (lower) were examined every month since the initiation of recombinant human growth hormones treatment; B: The patient’s body composition was assessed using dual-energy X-ray absorptiometry before and after growth hormone replacement therapy. HDL-C: High-density lipoprotein-cholesterol; IGF-1: Insulin-like growth factor-1; LDL-C: Low-density lipoprotein-cholesterol; TC: Total cholesterol; TG: Triglycerides total cholesterol.

Figure 2 Pentagon copying test. The Mini-Mental State Examination was conducted before and after 6-mo growth hormone replacement therapy. The drawings show the patient’s performance in copying the two overlapping pentagons.